Literature DB >> 26198655

Dose or 'LET' painting--What is optimal in particle therapy of hypoxic tumors?

Eirik Malinen1,2, Åste Søvik3.   

Abstract

BACKGROUND: Dose painting is a concept that may increase the tumor control probability (TCP). In particle therapy of hypoxic tumors, it may also be beneficial to redistribute the linear energy transfer (LET) so that the oxygen effect is minimized; so-called LET painting. The purpose of the present study was to use TCP estimates for comparing dose and LET painting of hypoxic tumors.
MATERIAL AND METHODS: Protons, lithium ions and carbon ions were considered. Tumor images tentatively depicting hypoxia were used as input. Optimal dose prescription maps were obtained by optimizing TCP under dose and/or LET redistribution. TCPs were compared to those resulting from conventional particle therapy with no dose or LET painting. The therapeutic gain at a given iso-effect was calculated. Treatment adaptation during therapy in response to changes in the spatial hypoxia distribution was also considered.
RESULTS: Both dose and LET painting gave higher TCPs compared to conventional particle therapy, irrespective of particle type. The therapeutic gain from LET painting, dose painting and combined dose+ LET painting was 1.09/1.43/1.45, 1.24/1.32/1.37 and 1.16/1.23/1.28 for protons, lithium ions and carbon ions, respectively. The importance of treatment adaptation was less pronounced for particles heavier than protons.
CONCLUSION: Dose painting results in higher TCP than LET painting, in particular for protons. For heavier ions, LET painting may also give an enhanced tumor effect compared to conventional particle therapy. Combined dose+ LET painting may only give a marginally increased effect compared to dose painting only. Adaptive carbon ion dose painting seems to be of less importance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26198655     DOI: 10.3109/0284186X.2015.1062540

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  6 in total

Review 1.  Radiobiological issues in proton therapy.

Authors:  Radhe Mohan; Christopher R Peeler; Fada Guan; Lawrence Bronk; Wenhua Cao; David R Grosshans
Journal:  Acta Oncol       Date:  2017-08-22       Impact factor: 4.089

2.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility.

Authors:  Eleanor A Blakely; Bruce Faddegon; Christopher Tinkle; Charles Bloch; Michael Dominello; Robert J Griffin; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.243

Review 3.  Hadrontherapy Interactions in Molecular and Cellular Biology.

Authors:  Juliette Thariat; Samuel Valable; Carine Laurent; Siamak Haghdoost; Elodie A Pérès; Myriam Bernaudin; François Sichel; Paul Lesueur; Mathieu Césaire; Edwige Petit; Aurélie E Ferré; Yannick Saintigny; Sven Skog; Mihaela Tudor; Michael Gérard; Sebastien Thureau; Jean-Louis Habrand; Jacques Balosso; François Chevalier
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

4.  Spot-Scanning Hadron Arc (SHArc) Therapy: A Study With Light and Heavy Ions.

Authors:  Stewart Mein; Thomas Tessonnier; Benedikt Kopp; Semi Harrabi; Amir Abdollahi; Jürgen Debus; Thomas Haberer; Andrea Mairani
Journal:  Adv Radiat Oncol       Date:  2021-02-04

5.  Development of a portable hypoxia chamber for ultra-high dose rate laser-driven proton radiobiology applications.

Authors:  Pankaj Chaudhary; Deborah C Gwynne; Boris Odlozilik; Aaron McMurray; Giuliana Milluzzo; Carla Maiorino; Domenico Doria; Hamad Ahmed; Lorenzo Romagnani; Aaron Alejo; Hersimerjit Padda; James Green; David Carroll; Nicola Booth; Paul McKenna; Satyabrata Kar; Giada Petringa; Roberto Catalano; Francesco P Cammarata; Giuseppe A P Cirrone; Stephen J McMahon; Kevin M Prise; Marco Borghesi
Journal:  Radiat Oncol       Date:  2022-04-15       Impact factor: 4.309

6.  Optimization of treatment planning for hypoxic tumours and re-modulation of radiation intensity in heavy-ion radiotherapy.

Authors:  Ladan Rezaee
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.